42 studies found for:    FDOPA
Show Display Options
Rank Status Study
1 Terminated Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme
Intervention: Drug: FDOPA PET
2 Terminated 18F FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly Diagnosed or Recurrent Gliomas
Conditions: Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Diffuse Astrocytoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Recurrent Adult Brain Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Cerebellar Astrocytoma;   Untreated Childhood Cerebral Astrocytoma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Visual Pathway and Hypothalamic Glioma;   Untreated Childhood Visual Pathway Glioma
Interventions: Drug: fluorine F 18 fluorodopa;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
3 Recruiting POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
Condition: Glioblastoma
Intervention: Other: impact of device 18F-FDOPA PET on treatment decisions
4 Recruiting Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study
Condition: Cancer (High-grace Glioma)
Intervention: Procedure: Surgical neuronavigation with 18F-DOPA PET imaging
5 Recruiting Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)
Conditions: Glioma;   Cerebral Metastases
Intervention: Other: PET 18FDOPA
6 Active, not recruiting Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism (CHI);   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
7 Not yet recruiting Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients
Condition: Parkinson`s Disease
Intervention: Drug: [18F]FDOPA PET/CT
8 Recruiting 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Conditions: Malignant Glioma;   Recurrent Brain Neoplasm
Interventions: Procedure: Biopsy;   Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Drug: Fluorine F 18 Fluorodopa;   Other: Laboratory Biomarker Analysis;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography;   Procedure: Therapeutic Conventional Surgery
9 Recruiting FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
Conditions: Glioma;   Malignant Glioma
Interventions: Drug: 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine;   Device: PET/MRI;   Procedure: Surgical resection (standard of care)
10 Recruiting Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study
Condition: Metastatic Melanoma
Intervention: Device: PET with 18F-FDOPA
11 Recruiting A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Condition: Malignant Glioma
Intervention: Drug: Fluorine-18-L-dihydroxyphenylalanine
12 Recruiting Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
Conditions: Astrocytoma, Oligoastrocytoma, Mixed;   Ganglioneuroma;   Glioma;   Ganglioglioma;   Glioblastoma Multiforme Glioma
Interventions: Drug: Irinotecan;   Drug: Bevacizumab;   Device: FDOPA-PET/MRI imaging
13 Available 18F-FDOPA PET in Neuroendocrine Tumours
Conditions: Thyroid Cancer, Medullary;   Carcinoid Tumor;   Pheochromocytoma;   Paraganglioma;   Insulinoma;   Neuroblastoma
Intervention: Drug: [18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA)
14 Active, not recruiting Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Conditions: Congenital Hyperinsulinism;   Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy;   CHI;   PHHI
Interventions: Drug: F-DOPA;   Radiation: PET scan
15 Completed Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)
Condition: Neuroendocrine Tumors
Intervention: Procedure: F-18-F-DOPA
16 Recruiting 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Condition: Malignant Glioma
Interventions: Procedure: Diffusion Weighted Imaging;   Drug: Fluorine F 18 Fluorodopa;   Radiation: Intensity-Modulated Radiation Therapy;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography;   Other: Quality-of-Life Assessment;   Drug: Temozolomide
17 Recruiting Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Conditions: Glioma;   Glioblastoma
Intervention: Drug: FDOPA PET/CT
18 Not yet recruiting Evaluation of Myocardial Sympathetic Denervation in Parkinson's Disease Using [18F]FDOPA
Condition: Parkinson
Interventions: Other: [18F]-DOPA;   Device: PET-CT
19 Active, not recruiting Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Diffuse Astrocytoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma
Interventions: Procedure: biopsy;   Procedure: computed tomography;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy treatment planning/simulation;   Radiation: radiation therapy;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Drug: fluorine F 18 fluorodopa
20 Active, not recruiting Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation
Conditions: Paragangliomas;   Pheochromocytomas
Intervention: Other: PET-CT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years